Professor Dr Geoffrey Smith

  • Section Microbiology and Immunology
  • Location Cambridge, United Kingdom
  • Election year 2011

Research

Main areas of research: Microbiology, virology, immunology, vaccinia virus, vaccines
Geoffrey L. Smith is a British microbiologist and virologist specialising in the area of poxviruses. His research examines the interaction of poxviruses with the infected host cell and the immune system, concentrating especially on the vaccinia virus (VACV) that was the vaccine used to eradicate smallpox. His research has enabled new vaccination concepts to be developed and provided important insights into how viruses evade the host innate immune response and cause disease.
VACV is a DNA‐virus that replicates in cytoplasm and encodes many proteins that suppress natural immunity. Smith discovered that the VACV expresses proteins that bind with interferons, cytokines and chemokines, which are molecules that cause the immune system to go into high gear after an infection. He was thus able to explain how the virus prevented itself from being halted. Moreover, Smith discovered that the family of poxviruses that includes variola and vaccinia utilises a specific mechanism for rapidly spreading to other cells.
His research activities have contributed to a better understanding of the way in which viruses multiply after having infected a cell and then spread to other cells and how they are able to overcome the body´s immune system in the process. These findings are important for developing better vaccines based on poxviruses.

  • since 2011 Chair of the Pathology Department, University of Cambridge, UK and Principal Research Fellow, Wellcome Trust
  • 2000 ‐ 2011 Director, Department of Virology, Imperial College London, UK
  • 1989 ‐ 2000 Reader then Professor, University of Oxford, UK
  • 1985 ‐ 1989 Lecturer in Virology, University of Cambridge, UK
  • 1981 ‐ 1984 Postdoctoral Fellow, National Institutes of Health, Bethesda, USA
  • 1981 PhD, National Institute for Medical Research, Mill Hill, London, UK

  • since 2015 Chair of the scientific council, Friedrich Löffler Institute
  • 2012 ‐ 2016 Member, Biomedical Panel of the University Research Grant Committee, Hong Kong
  • 2011 ‐ 2014 President, International Union of Microbiological Societies
  • 2009 ‐ 2012 Chair, Royal Society Committee for Scientific Aspects of International Security
  • 2008 ‐ 2011 Member of the Royal Society Science Policy Advisory Group
  • since 2004 Chair, WHO Advisory Committee for Variola Virus (smallpox) Research
  • 2003 ‐ 2013 Governor of the Lister Institute for Preventive Medicine

  • 2012 Glaxo Smith Kline/ American Society for Microbiology International Member of the Year Award
  • since 2011 Member of the German National Academy of Sciences Leopoldina
  • 2008 Founding member of the European Academy of Microbiology
  • 2005 Feldberg Foundation Prize in Medical and Biological Science
  • since 2003 Fellow of the Royal Society
  • since 2002 Fellow of the Institute of Biology
  • since 2002 Fellow of the Academy of Medical Sciences
  • 1992 Fleming Award of the Society for General Microbiology

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸